RESUMEN
A new series of 3-hydroxy-2-pyridine aldoxime compounds have been designed, synthesised and tested in vitro, in silico, and ex vivo as reactivators of human acetylcholinesterase (hAChE) and butyrylcholinesterase (hBChE) inhibited by organophosphates (OPs), for example, VX, sarin, cyclosarin, tabun, and paraoxon. The reactivation rates of three oximes (16-18) were determined to be greater than that of 2-PAM and comparable to that of HI-6, two pyridinium aldoximes currently used by the armies of several countries. The interactions important for a productive orientation of the oxime group within the OP-inhibited enzyme have been clarified by molecular-modelling studies, and by the resolution of the crystal structure of the complex of oxime 17 with Torpedo californica AChE. Blood-brain barrier penetration was predicted for oximes 15-18 based on their physicochemical properties and an in vitro brain membrane permeation assay. Among the evaluated compounds, two morpholine-3-hydroxypyridine aldoxime conjugates proved to be promising reactivators of OP-inhibited cholinesterases. Moreover, efficient ex vivo reactivation of phosphylated native cholinesterases by selected oximes enabled significant hydrolysis of VX, sarin, paraoxon, and cyclosarin in whole human blood, which indicates that the oximes have scavenging potential.
Asunto(s)
Barrera Hematoencefálica/metabolismo , Butirilcolinesterasa/metabolismo , Organofosfatos/química , Oximas/química , Barrera Hematoencefálica/química , Butirilcolinesterasa/química , Humanos , Relación Estructura-ActividadRESUMEN
Since the September 11, 2001, terrorist attacks in the United States, the specter of a chemical threat against civilian populations has renewed research interest in chemical warfare agents, their mechanisms of action, and treatments that reverse their effects. In this Account, we focus specifically on organophosphorus nerve agents (OPNAs). Although some OPNAs are used as pest control, the most toxic chemicals in this class are used as chemical warfare agents in armed conflicts. The acute toxicity of OPNAs results from the irreversible inhibition of acetylcholinesterase (AChE, EC 3.1.1.7) via the formation of a covalent P-O bond at the serine hydroxyl group in the enzyme active site. AChE breaks down the neurotransmitter acetylcholine at neuronal synapses and neuromuscular junctions. The irreversible inhibition of AChE causes the neurotransmitter to accumulate in the synaptic cleft, leading to overstimulation of cholinergic receptors, seizures, respiratory arrest, and death. The current treatment for OPNA poisoning combines an antimuscarinic drug (e.g., atropine), an anticonvulsant drug (e.g., diazepam), and an AChE reactivator of the pyridinium aldoxime family (pralidoxime, trimedoxime, obidoxime, HI-6, HLö-7). Because of their high nucleophilicity, oximes can displace the phosphyl group from the catalytic serine, thus restoring the enzyme's catalytic activity. During 50 years of research in the reactivator field, researchers have synthesized and tested numerous structural modifications of monopyridinium oximes and bispyridinium oximes. In the past decade, medicinal chemists have focused their research on the more efficient bispyridinium reactivators, but all known reactivators have several drawbacks. First, due to their permanent positive charge, they do not cross the blood-brain barrier (BBB) efficiently and do not readily reactivate AChE in the central nervous system. Second, no single oxime is efficient against a wide variety of OPNAs. Third, oximes cannot reactivate "aged" AChE. This Account summarizes recent strategies for the development of AChE reactivators capable of crossing the BBB. The use of nanoparticulate transport and inhibition of P-glycoprotein efflux pumps improves BBB transport of these AChE reactivators. Chemical modifications that increased the lipophilicity of the pyridinium aldoximes, the addition of a fluorine atom and the replacement of a pyridyl ring with a dihydropyridyl moiety, enhances BBB permeability. The glycosylation of pyridine aldoximes facilitates increased BBB penetration via the GLUT-1 transport system. The development of novel uncharged reactivators that can move efficiently across the BBB represents one of the most promising of these new strategies.
Asunto(s)
Antídotos/farmacología , Sustancias para la Guerra Química/toxicidad , Reactivadores de la Colinesterasa/química , Reactivadores de la Colinesterasa/farmacología , Compuestos Organofosforados/toxicidad , Antídotos/química , Barrera Hematoencefálica/efectos de los fármacos , Sustancias para la Guerra Química/envenenamiento , Inhibidores de la Colinesterasa/envenenamiento , Diseño de Fármacos , Humanos , Nanopartículas , Intoxicación por Organofosfatos , Oximas/química , Oximas/farmacología , Compuestos de Piridinio/química , Compuestos de Piridinio/farmacología , Relación Estructura-ActividadRESUMEN
A one-pot synthesis of various N-substituted 3-amino-thiochromanes from 4-benzyl-2-methyl thiazoline via a thiazolinium salt is described. The obtained 3-amino-thiochromanes are enantiopure, as their precursors derive from chiral 2-aminoalcohols. The reaction involves the formation of a disulfide, which subsequently takes part in an unprecedented intramolecular electrophilic aromatic substitution.
Asunto(s)
Compuestos Bicíclicos Heterocíclicos con Puentes/síntesis química , Tiazoles/química , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Cristalografía por Rayos X , Estructura Molecular , EstereoisomerismoRESUMEN
Organophosphorus nerve agents, like VX, are highly toxic due to their strong inhibition potency against acetylcholinesterase (AChE). AChE inhibited by VX can be reactivated using powerful nucleophilic molecules, most commonly oximes, which are one major component of the emergency treatment in case of nerve agent intoxication. We present here a comparative in vivo study on Swiss mice of four reactivators: HI-6, pralidoxime and two uncharged derivatives of 3-hydroxy-2-pyridinaldoxime that should more easily cross the blood-brain barrier and display a significant central nervous system activity. The reactivability kinetic profile of the oximes is established following intraperitoneal injection in healthy mice, using an original and fast enzymatic method based on the reactivation potential of oxime-containing plasma samples. HI-6 displays the highest reactivation potential whatever the conditions, followed by pralidoxime and the two non quaternary reactivators at the dose of 50 mg/kg bw. But these three last reactivators display equivalent reactivation potential at the same dose of 100 µmol/kg bw. Maximal reactivation potential closely correlates to surviving test results of VX intoxicated mice.
Asunto(s)
Análisis Químico de la Sangre/métodos , Barrera Hematoencefálica/efectos de los fármacos , Sustancias para la Guerra Química/toxicidad , Reactivadores de la Colinesterasa/sangre , Compuestos Organotiofosforados/toxicidad , Oximas/farmacología , Compuestos de Pralidoxima/farmacología , Compuestos de Piridinio/farmacología , Acetilcolinesterasa/química , Acetilcolinesterasa/metabolismo , Animales , Barrera Hematoencefálica/metabolismo , Eritrocitos/citología , Eritrocitos/enzimología , Semivida , Humanos , Inyecciones Intraperitoneales , Masculino , Ratones , Oximas/metabolismo , Compuestos de Pralidoxima/metabolismo , Sustancias Protectoras/metabolismo , Sustancias Protectoras/farmacología , Compuestos de Piridinio/metabolismoRESUMEN
Organophosphorus nerve agents (OPNAs) are highly toxic compounds that represent a threat to both military and civilian populations. They cause an irreversible inhibition of acetylcholinesterase (AChE), by the formation of a covalent P-O bond with the catalytic serine. Among the present treatment of nerve agents poisoning, pyridinium and bis-pyridinium aldoximes are used to reactivate this inhibited enzyme but these compounds do not readily cross the blood brain barrier (BBB) due to their permanent cationic charge and thus cannot efficiently reactivate cholinesterases in the central nervous system (CNS). In this study, a series of seven new uncharged oximes reactivators have been synthesized and their in vitro ability to reactivate VX and tabun-inhibited human acetylcholinesterase (hAChE) has been evaluated. The dissociation constant K(D) of inhibited enzyme-oxime complex, the reactivity rate constant kr and the second order reactivation rate constant k(r2) have been determined and have been compared to reference oximes HI-6, Obidoxime and 2-Pralidoxime (2-PAM). Regarding the reactivation of VX-inhibited hAChE, all compounds show a better reactivation potency than those of 2-PAM, nevertheless they are less efficient than obidoxime and HI-6. Moreover, one of seven described compounds presents an ability to reactivate tabun-inhibited hAChE equivalent to those of 2-PAM.
Asunto(s)
Acetilcolinesterasa/metabolismo , Sustancias para la Guerra Química/toxicidad , Inhibidores de la Colinesterasa/toxicidad , Reactivadores de la Colinesterasa/síntesis química , Reactivadores de la Colinesterasa/farmacología , Compuestos Organofosforados/toxicidad , Reactivadores de la Colinesterasa/química , Evaluación Preclínica de Medicamentos , Electroquímica , Proteínas Ligadas a GPI/metabolismo , Humanos , Estructura Molecular , Cloruro de Obidoxima/farmacología , Oximas/síntesis química , Oximas/química , Oximas/farmacología , Compuestos de Pralidoxima/farmacología , Compuestos de Piridinio/farmacología , Proteínas Recombinantes/metabolismoRESUMEN
Pyridinium and bis-pyridinium aldoximes are used as antidotes to reactivate acetylcholinesterase (AChE) inhibited by organophosphorus nerve agents. Herein, we described a series of nine nonquaternary phenyltetrahydroisoquinoline-pyridinaldoxime conjugates more efficient than or as efficient as pyridinium oximes to reactivate VX-, tabun- and ethyl paraoxon-inhibited human AChE. This study explores the structure-activity relationships of this new family of reactivators and shows that 1b-d are uncharged hAChE reactivators with a broad spectrum.
Asunto(s)
Acetilcolinesterasa/metabolismo , Inhibidores de la Colinesterasa/farmacología , Reactivadores Enzimáticos/farmacología , Isoquinolinas/farmacología , Oximas/farmacología , Acetilcolinesterasa/efectos de los fármacos , Humanos , Espectroscopía de Resonancia Magnética , FosforilaciónRESUMEN
Nerve agents are highly toxic organophosphorus compounds with strong inhibition potency against acetylcholinesterase (AChE). Herein, we describe two first extremely promising uncharged reactivators for poisoned human AChE with a superior or similar in vitro ability to reactivate the enzyme as compared to that of HI-6, obidoxime, TMB-4 and HLö-7.
Asunto(s)
Inhibidores de la Colinesterasa/farmacología , Eritrocitos/enzimología , Compuestos Organofosforados/química , Piridinas/farmacología , Compuestos de Piridinio/farmacología , Acetilcolinesterasa/metabolismo , Humanos , Estructura Molecular , Cloruro de Obidoxima/metabolismo , Organofosfatos/metabolismo , Oximas/química , Soman/metabolismoRESUMEN
The aim of the present investigation was to apply a chemical delivery system (CDS) to MIBG (4) with the purpose of delivering this drug to the CNS. Compound 4 has been linked to a 1,4-dihydroquinoline moiety in order to achieve its CNS penetration, and here we report the synthesis to link 4 to the chemical delivery system and the radiosynthesis with carbon-11 of the "CDS-4 entity". After iv injection into rats of the [(11)C]CDS-4, the follow-up study of the radioactivity distribution in blood samples and brain homogenates and the analysis by HPLC and LC-MS/MS have confirmed the release of 4 into the CNS.